Our study supports and extends these studies, linking IL-33 signaling to gastric tumorigenesis; whereas Eissmann et al. investigated the impact of genetic deficiency in ST2, the cognate receptor for IL33 in GC, [32] we show a direct functional requirement for IL-33 as a driver of GC pathogenesis. Here, IL33 is linked to gastric cancer.